Light & Wonder, Inc. ("Light & Wonder," "L&W," "we" or the "Company") is providing an update on today's ruling from the Nevada Court regarding the ongoing litigation with Aristocrat. The Nevada Court ...

Merck leads U.S. pharma in 2025, but faces Keytruda patent loss by 2028. Click for my look at MRK stock ahead of its upcoming ...

Antibody–drug conjugates have emerged as a powerful tool to deliver highly targeted cancer therapies. Next-generation antibody-drug conjugate designs aim to push the envelope even further.

Phonons are indeed recognized as vibrations of the lattice that transport heat energy in solids. To contemplate on the idea ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last year's ...